CSIMarket



Moderna Inc.  (MRNA)
Other Ticker:  
 

Cumulative Moderna's Leverage Ratio for Trailing Twelve Months Period

MRNA's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

MRNA Leverage Ratio for Trailing Twelve Months Period

(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Equity Growth 168.27 % 344.89 % 452.24 % 266.84 % 127.49 %
Y / Y Total Liabilities Growth -14.72 % 18.86 % 120.38 % 469.17 % 1632.92 %
Leverage Ratio for Trailing Twelve Months Period 0.67 0.86 1.14 1.46 1.57
Total Ranking # 1470 # 1794 # 2389 # 2233 # 2349
Seq. Equity Growth 5.33 % 20.71 % 39.72 % 51.01 % 74.67 %
Seq. Total Liabilities Growth -23.5 % 0.1 % -2.55 % 14.29 % 6.62 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to debt repayement of -23.5% Moderna decreased Leverage Ratio for Trailing Twelve Months Period in the II. Quarter to 0.67, below company's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 148 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Moderna. While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 1470, from total ranking in previous quarter at 1794.

What is Leverage Ratio?
Who are MRNA's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 149
Sector # 580
S&P 500 # 1469


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.18 1.04 0.22
(Jun 30 2019)   (Jun 30 2020)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2022, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Gilead Sciences Inc.  1.85 
Humacyte Inc.  1.80 
Isoplexis Corporation  1.77 
Reynolds Consumer Products Inc.  1.76 
Nanostring Technologies Inc.  1.75 
Vicarious Surgical Inc.  1.75 
Codiak Biosciences Inc.  1.62 
U.s. Lighting Group Inc.  1.51 
Innate Pharma Sa  1.49 
Genfit S a   1.37 
Adma Biologics Inc.  1.28 
Aytu Biopharma inc.  1.24 
Trees Corporation  1.22 
Eloxx Pharmaceuticals Inc.  1.21 
Outlook Therapeutics Inc.  1.21 
Unity Biotechnology Inc.  1.20 
Biogen Inc.  1.17 
Axcella Health Inc.  1.14 
Eargo Inc.  1.12 
Royalty Pharma Plc  1.11 
Allena Pharmaceuticals Inc.  1.08 
Adaptimmune Therapeutics Plc  1.05 
Champions Oncology Inc.  1.02 
Brooklyn Immunotherapeutics Inc.  0.99 
Eyenovia inc.  0.95 
Taysha Gene Therapies Inc.  0.93 
Sangamo Therapeutics Inc.  0.91 
Oyster Point Pharma Inc.  0.90 
Soligenix inc   0.89 
Cytrx Corporation  0.88 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ARBE's Profile

Stock Price

ARBE's Financials

Business Description

Fundamentals

Charts & Quotes

ARBE's News

Suppliers

ARBE's Competitors

Customers & Markets

Economic Indicators

ARBE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071